Literature DB >> 26085983

Placebo effect in osteoarthritis: Why not use it to our advantage?

Gustavo C de Campos1.   

Abstract

Osteoarthritis is a major cause of pain and reduced quality of life in the elderly, as well as a major economic burden. Unfortunately, there is no currently effective therapeutic strategy to prevent the progression of Osteoarthritis, and its treatment poses a great challenge to the medical community. Most of the treatment modalities currently available for osteoarthritis have small to moderate effect sizes, according to main meta-analyses and treatment guidelines. On the other hand, literature has demonstrated that placebo is considerably effective. The present article discusses the history of placebo effect and its scientific evidence, comments on ethical issues and provides insights about how it may be used to our advantage when treating osteoarthritic patients.

Entities:  

Keywords:  Osteoarthritis; Placebo; Treatment

Year:  2015        PMID: 26085983      PMCID: PMC4458492          DOI: 10.5312/wjo.v6.i5.416

Source DB:  PubMed          Journal:  World J Orthop        ISSN: 2218-5836


  30 in total

1.  The powerful placebo.

Authors:  H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-12-24

2.  Commercial features of placebo and therapeutic efficacy.

Authors:  Rebecca L Waber; Baba Shiv; Ziv Carmon; Dan Ariely
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272

Review 3.  The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials.

Authors:  W Zhang; J Robertson; A C Jones; P A Dieppe; M Doherty
Journal:  Ann Rheum Dis       Date:  2008-06-09       Impact factor: 19.103

4.  Double-blind versus deceptive administration of a placebo.

Authors:  I Kirsch; L J Weixel
Journal:  Behav Neurosci       Date:  1988-04       Impact factor: 1.912

5.  Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis.

Authors:  Chin Lee; Elke Hunsche; Robert Balshaw; Sheldon X Kong; Thomas J Schnitzer
Journal:  Arthritis Rheum       Date:  2005-08-15

Review 6.  Overt versus covert treatment for pain, anxiety, and Parkinson's disease.

Authors:  Luana Colloca; Leonardo Lopiano; Michele Lanotte; Fabrizio Benedetti
Journal:  Lancet Neurol       Date:  2004-11       Impact factor: 44.182

Review 7.  Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  J Intern Med       Date:  2004-08       Impact factor: 8.989

8.  OARSI guidelines for the non-surgical management of knee osteoarthritis.

Authors:  T E McAlindon; R R Bannuru; M C Sullivan; N K Arden; F Berenbaum; S M Bierma-Zeinstra; G A Hawker; Y Henrotin; D J Hunter; H Kawaguchi; K Kwoh; S Lohmander; F Rannou; E M Roos; M Underwood
Journal:  Osteoarthritis Cartilage       Date:  2014-01-24       Impact factor: 6.576

9.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

10.  Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear.

Authors:  Raine Sihvonen; Mika Paavola; Antti Malmivaara; Ari Itälä; Antti Joukainen; Heikki Nurmi; Juha Kalske; Teppo L N Järvinen
Journal:  N Engl J Med       Date:  2013-12-26       Impact factor: 91.245

View more
  6 in total

1.  Efficacy and safety of a single intra-articular injection of 6 ml Hylan G-F 20 compared to placebo in Chinese patients with symptomatic knee osteoarthritis : C-SOUND study, a 26-week multicenter double-blind randomized placebo-controlled trial in China.

Authors:  Yan Ke; Wenxue Jiang; Yongsheng Xu; Yajun Chen; Qingsong Zhang; Qingyun Xue; Jianhao Lin; Wilson Ngai; Gaowei Nian; Mir Sohail Fazeli; Yao Xie; Zhenan Zhu
Journal:  BMC Musculoskelet Disord       Date:  2021-05-08       Impact factor: 2.362

2.  Cryoneurolysis for the management of chronic pain in patients with knee osteoarthritis; a double-blinded randomized controlled sham trial.

Authors:  Niels-Peter Brøchner Nygaard; Carsten Koch-Jensen; Henrik Bjarke Vægter; Niels Wedderkopp; Morten Blichfeldt-Eckhardt; Bibi Gram
Journal:  BMC Musculoskelet Disord       Date:  2021-02-26       Impact factor: 2.362

3.  Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.

Authors:  Jean-Pierre Pelletier; Jean-Pierre Raynauld; André D Beaulieu; Louis Bessette; Frédéric Morin; Artur J de Brum-Fernandes; Philippe Delorme; Marc Dorais; Patrice Paiement; François Abram; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2016-11-03       Impact factor: 5.156

4.  Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study.

Authors:  D Kuah; S Sivell; T Longworth; K James; A Guermazi; F Cicuttini; Y Wang; S Craig; G Comin; D Robinson; J Wilson
Journal:  J Transl Med       Date:  2018-03-06       Impact factor: 5.531

5.  Can we improve pain and sleep in elderly individuals with transcranial direct current stimulation? - Results from a randomized controlled pilot study.

Authors:  Marie-Philippe Harvey; Dominique Lorrain; Marylie Martel; Kayla Bergeron-Vezina; Francis Houde; Mario Séguin; Guillaume Léonard
Journal:  Clin Interv Aging       Date:  2017-06-06       Impact factor: 4.458

6.  A Pilot Clinical Study of Hyperacute Serum Treatment in Osteoarthritic Knee Joint: Cytokine Changes and Clinical Effects.

Authors:  Isabel Olmos Calvo; Eszter Fodor; Dorottya Kardos; István Hornyák; Adél Hinsenkamp; Olga Kuten-Pella; Zsuzsanna Gyevnár; Gábor Erdélyi; Tamás Bárdos; Tamás Mirkó Paukovits; Krisztián Magos; György Béres; Stefan Nehrer; Zsombor Lacza
Journal:  Curr Issues Mol Biol       Date:  2021-07-09       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.